Techniques in Coloproctology
Cure8 research brief
Why This Matters
People with IBD and their clinicians often worry that anorectal surgery like hemorrhoidectomy could cause complications, flares, or loss of continence. This study suggests that, in a selected multicenter European cohort, outcomes were generally favorable, which may support individualized surgical decision-making.
Who Should Pay Attention
Adult patients with ulcerative colitis or Crohn’s disease considering hemorrhoidal surgery; colorectal surgeons and gastroenterologists; researchers studying surgical outcomes in IBD.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The HEAD-IBD study pooled adults with established UC or CD who had hemorrhoidal surgery and at least 12 months follow-up (2004–2024). Open excisional hemorrhoidectomy was the most common procedure.
Surgical complications within 30 days and 6 months were observed mainly in UC patients and were mostly mild; no 30-day or 6-month surgical complications were reported for CD patients in this cohort. Within 6 months after surgery, about 16% experienced an IBD flare (similar proportions between UC and CD).
New-onset perianal disease occurred in a minority (13%), more often in CD, and new-onset incontinence was rare and managed conservatively. The authors conclude that hemorrhoidal surgery in selected IBD patients had low morbidity and preserved anorectal function, and they call for prospective studies to confirm these findings.
Keep In Mind
This is a retrospective cohort with 38 patients and 2004–2024 enrollment; results are encouraging but limited by sample size, retrospective design, and potential selection bias. The source content depth is an abstract; conclusions should be confirmed by prospective, larger studies.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationTechniques in Coloproctology
PublisherSpringer Science and Business Media LLC
AuthorsC. Felice, D. Pugliese, G. Gallo +15 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedJul 26, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: Università degli Studi di Padova
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Safety of Biologic and Immune-Modulating Agents in Breast Augmentation and Reconstruction
People with IBD often take biologics and may need or want implant-based breast surgery.
Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN®) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study.
This study reports real-world outcomes with granulocyte and monocyte adsorptive apheresis (GMA) in patients with refractory IBD, showing steroid-free remission by week 14 in about one-third of patients and continued...
Predicting Postoperative Complications in Patients Undergoing Surgery for Inflammatory Bowel Disease.
Understanding which patients are at higher risk for serious complications after IBD surgery can help patients and clinicians weigh risks, plan preoperative optimization, and guide research into preventive strategies.